A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

Clinical trial NCT01392573 · COMPLETED

Trial details

NCT number: NCT01392573
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 2

Start date: 2011-11-28
Primary completion: 2012-10-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.